Günter Oberdörster, University of Rochester
|
Günter Oberdörster, Ph.D., is Professor of Environmental Medicine and Head of the Division of Respiratory Biology & Toxicology at the School of Medicine & Dentistry in the University of Rochester, and Director of the University of Rochester Ultrafine Particle Center. He has extensive expertise in the toxicology and health effects of air pollutants, their risk assessment and toxicokinetics. He is also director of the Ph.D. Program in Toxicology. He has served on national and international committees, among others: NIEHS study sections, EPA’s Science Advisory Board committees, Board of Scientific Counselors of the National Toxicology Program, NRC’s Committee on Toxicology, TLV Committee of the American Conference of Governmental Industrial Hygienists, several working groups of the Intl. Agency for Research on Cancer (IARC), WHO consultancies, IUPAC Commission on Toxicology, ad hoc Expert Group on Chemicals Bureau of the European Commission, and advisory panel of the German Research Association. He has served on EPA's Clean Air Scientific Advisory Committee (CASAC) and on NRC’s Committee on Research Priorities for Airborne Particulate Matter. Prof. Oberdörster earned his D.V.M. and Ph.D. (Pharmacology) from the University of Giessen in Germany. He is known for his research on the effects and underlying mechanisms of lung injury induced by inhaled non-fibrous and fibrous particles, including extrapolation modeling and risk assessment. His research on with ultrafine particles influenced the field of inhalation toxicology, raising awareness of their unique toxicological potential. Prof. Oberdörster’s research interests center on the toxicology of Airborne Environmental and Occupational Particles, with more recent activities in nanotoxicology, investigating the unique biokinetics and toxicological potential of engineered nanoparticles, and the propensity of these particles of different shapes (e.g., spheres, tubes, rods), different chemistries (e.g., metals, semiconductors, carbon) and different surface characteristics (coating, charge, porosity) to translocate from the site of deposition in the respiratory tract to extrapulmonary organs such as heart, liver, bone marrow and brain. Oberdörster G, Oberdörster E, Oberdörster J. Concepts of nanoparticle dose metric and response metric. Environ Health Perspect. 2007 115, A290. Elder A, Oberdörster G. Translocation and effects of ultrafine particles outside of the lung. Clin Occup Environ Med. 2006 5, 785-796. Oberdörster G, Oberdörster E, Oberdörster J. Nanotoxicology: An Emerging Discipline Evolving from Studies of Ultrafine Particles. Environ Health Perspect 2005 113, 823-839. |
|
 |
 |
